Filing Flows › Procept BioRobotics (PRCT) › Recalls, complaints & regulation

Procept BioRobotics (PRCT): clinical trials

Procept BioRobotics (PRCT) beyond its filings: 3 active clinical trials.

Procept BioRobotics' latest quarter

Procept BioRobotics, Q3 2026: revenue $98.3M (+18% year over year), operating margin -27.9%, net loss $26.5M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Procept BioRobotics have?

3 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.